ENGIOSOME Trademark

Trademark Overview


On Wednesday, April 6, 2022, a trademark application was filed for ENGIOSOME with the United States Patent and Trademark Office. The USPTO has given the ENGIOSOME trademark a serial number of 97349784. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Codiak Biosciences, Inc.. The ENGIOSOME trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for use in oncology, immune-oncology, neurology, infectious diseases, and genetic diseases and disorders; Pharmaceutical and biological preparations for preventing, managing and treating cancer, infectious diseases, and metabolic, fibrotic, immune, and neurological diseases and disorders; biological preparations in the nature of biological components, namely, engineered exosomes used for the delivery of therapeutic agents to targeted cells and tissues within the human body; biological preparations in the nature of biological components, namely, engineered exosomes being a component in therapeutic preparations for use in cancer, infectious diseases, metabolic, fibrotic, immune, and neurological diseases and disorders

Scientific testing and medical and scientific research and development services in the fields of pharmaceuticals, biologics, exosomes, precision cell engineering, drug loading, gene delivery, and exosome therapeutics; Drug discovery services; Providing scientific information in the fields of pharmaceuticals, biologics, exosomes, precision cell engineering, drug loading, gene delivery, and exosome therapeutics
engiosome

General Information


Serial Number97349784
Word MarkENGIOSOME
Filing DateWednesday, April 6, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for use in oncology, immune-oncology, neurology, infectious diseases, and genetic diseases and disorders; Pharmaceutical and biological preparations for preventing, managing and treating cancer, infectious diseases, and metabolic, fibrotic, immune, and neurological diseases and disorders; biological preparations in the nature of biological components, namely, engineered exosomes used for the delivery of therapeutic agents to targeted cells and tissues within the human body; biological preparations in the nature of biological components, namely, engineered exosomes being a component in therapeutic preparations for use in cancer, infectious diseases, metabolic, fibrotic, immune, and neurological diseases and disorders
Goods and ServicesScientific testing and medical and scientific research and development services in the fields of pharmaceuticals, biologics, exosomes, precision cell engineering, drug loading, gene delivery, and exosome therapeutics; Drug discovery services; Providing scientific information in the fields of pharmaceuticals, biologics, exosomes, precision cell engineering, drug loading, gene delivery, and exosome therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLONZA SALES AG
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressBASEL CH-4052
CH

Party NameCodiak Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameCodiak Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 14, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION E-MAILED
Friday, January 27, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 24, 2023ASSIGNED TO EXAMINER
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 9, 2022NEW APPLICATION ENTERED